Injected Benlysta Is Effective Alternative to IV for Treating Lupus, Phase 3 Trial Shows
An injected formulation of Benlysta (belimumab) is a safe and effective lupus treatment, according to a Phase 3 clinical trial that tested an alternative to administering the therapy intravenously. Researchers reported the results of the 52-week BLISS-SC trial in Arthritis & Rheumatology. The article was titled “…